C4 Therapeutics, Inc.C4 Therapeutics, Inc.C4 Therapeutics, Inc.

C4 Therapeutics, Inc.

No trades
See on Supercharts

Price target

15.420.000.00%
The 6 analysts offering 1 year price forecasts for CCCC have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to CCCC in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CCCC EPS for the last quarter is −0.37 USD despite the estimation of −0.44 USD. In the next quarter EPS is expected to reach −0.41 USD. Track more of C4 Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter C4 Therapeutics, Inc. revenue is expected to reach ‪5.93 M‬ USD. Check out C4 Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, CCCC price target is 15.42 USD with a max estimate of 50.00 USD and a min estimate of 3.00 USD. Check if this forecast comes true in a year, meanwhile watch C4 Therapeutics, Inc. stock price chart and keep track of the current situation with CCCC news and stock market news.
We've gathered opinions of 8 analysts rating CCCC stock in the past 3 months. After counting all points of view, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.